Adaptive cytoprotection mediated by prostaglandin I(2) is attributable to sensitization of CRGP-containing sensory nerves

Gastroenterology. 2001 Jan;120(1):134-43. doi: 10.1053/gast.2001.20916.

Abstract

Background & aims: The phenomenon by which the gastric mucosa is protected in response to mild irritants has been called adaptive cytoprotection, a mechanism believed to be related to production of endogenous prostaglandins (PGs). We tested whether PGs generated by mild irritant prevent injury through the release of calcitonin gene-related peptide (CGRP) from the sensory nerves using prostanoid receptor-knockout mice.

Methods: The stomach was doubly cannulated and perfused with 1 mol/L NaCl or 50% ethanol. CGRP levels in the perfusate were determined by enzyme immunoassay, and the injured area was estimated at the end of perfusion.

Results: Preperfusion with mildly hypertonic saline (1 mol/L NaCl) increased generation of gastric PGE(2) and PGI(2) and reduced ethanol-induced mucosal damage. Exposure of ethanol after 1 mol/L NaCl increased intragastric CGRP levels from 166 +/- 27 to 713 +/- 55 pg/2 min (n = 4, P < 0.05), and the protective action of 1 mol/L NaCl was inhibited by indomethacin treatment. CGRP antagonist blocked 1 mol/L NaCl-induced protective effect. Intragastric perfusion of 50% ethanol after administration of PGI(2), but not of PGE(2), increased CGRP levels. Application of 1 mol/L NaCl to IP receptor-knockout mice (IP(-/-)) did not elicit the protective effects seen in the wild-type on ethanol-induced gastric mucosal lesions. Protective effect of 1 mol/L NaCl was observed in EP3 receptor-knockout mice (EP3(-/-)). CGRP level during ethanol perfusion was not increased in IP(-/-) but was increased in EP3(-/-) and wild-type counterparts after preperfusion of 1 mol/L NaCl.

Conclusions: These results indicate that the endogenous PGI(2) generated by 1 mol/L NaCl may have a protective role in gastric mucosal injury through enhancement of CGRP release from gastric mucosa. This mechanism may explain the adaptive cytoprotection observed after treatment with mild irritants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / metabolism
  • Adaptation, Physiological / drug effects
  • Anesthesia
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Calcitonin Gene-Related Peptide / antagonists & inhibitors
  • Calcitonin Gene-Related Peptide / metabolism*
  • Calcitonin Gene-Related Peptide / pharmacology
  • Central Nervous System Depressants / pharmacology
  • Dinoprostone / metabolism
  • Dinoprostone / pharmacology
  • Epoprostenol / metabolism*
  • Ethanol / pharmacology
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / innervation*
  • Gastric Mucosa / metabolism*
  • Indomethacin / pharmacology
  • Male
  • Mice
  • Mice, Knockout
  • Neurons, Afferent / metabolism*
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / metabolism*
  • Peptide Fragments / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Epoprostenol
  • Receptors, Prostaglandin / genetics
  • Sodium Chloride / pharmacology
  • Stomach Ulcer / chemically induced
  • Stomach Ulcer / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Central Nervous System Depressants
  • Peptide Fragments
  • Ptgir protein, mouse
  • Ptgir protein, rat
  • Receptors, Epoprostenol
  • Receptors, Prostaglandin
  • calcitonin gene-related peptide (8-37)
  • Ethanol
  • Sodium Chloride
  • 6-Ketoprostaglandin F1 alpha
  • Epoprostenol
  • Calcitonin Gene-Related Peptide
  • Dinoprostone
  • Indomethacin